InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（13 笔）
内部人交易记录
其他已披露买入
1
已披露卖出
13
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Gorman Kevin Charles. Insider active across 2 companies, notably Neurocrine Biosciences INC. Cumulatively, 28 reports have been logged. Breakdown: 1 buy · 13 sells. Total volume traded: €36.4m. Activity tracked since 7 February 2022. The latest transaction was filed on 16 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Gorman Kevin Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报28 总计
10,302 股0Common StockSEC:0001201096-26-000016:0
205,088 股@ US$43.240.048% mcap15.4% 占其流量Common StockSEC:0001201096-26-000010:0
245,088 股@ US$154.33180.20% mcap65.5% 占其流量Common StockSEC:0001201096-26-000010:1
5,604 股0Common StockSEC:0001201096-26-000005:0
5,142 股0Common StockSEC:0001201096-26-000003:0
106,322 股@ US$35.996.2% 占其流量Common StockSEC:0000914475-25-000166:0
13,686 股0Common StockSEC:0001127602-25-017597:0
9,613 股@ US$120.37981.9% 占其流量Common StockSEC:0000914475-25-000137:0
5,376 股0Common StockSEC:0000914475-25-000073:0
4,318 股0Common StockSEC:0000914475-25-000052:0
5,141 股0Common StockSEC:0000914475-25-000031:0
146,105 股@ US$32.999.3% 占其流量Common StockSEC:0000914475-25-000009:0
2,654 股@ US$20.6898.1% 占其流量Common StockSEC:0001127602-24-024672:0
5,986 股0Common StockSEC:0001127602-24-018831:0
53 股@ US$19.121.9% 占其流量Common StockSEC:0001127602-24-005195:0
标准退出：2024年5月13日 (T+90)
2,832 股@ US$133.01570.7% 占其流量Common StockSEC:0000914475-24-000073:0
2,778 股@ US$35.990.2% 占其流量Common StockSEC:0000914475-24-000056:0
3,040 股@ US$142.17710.8% 占其流量Common StockSEC:0000914475-24-000046:0
2,707 股@ US$140.68880.7% 占其流量Common StockSEC:0000914475-24-000028:0
105,835 股@ US$19.593.8% 占其流量Common StockSEC:0000914475-24-000009:0
9,328 股@ US$107.39881.8% 占其流量Common StockSEC:0001209191-23-047137:0
5,007 股0Common StockSEC:0001127602-23-019287:0
3,040 股@ US$105.67720.6% 占其流量Common StockSEC:0001209191-23-007912:0
2,707 股@ US$110.08390.6% 占其流量Common StockSEC:0001209191-23-006276:0
2,422 股@ US$80.82520.3% 占其流量Common StockSEC:0001209191-22-008211:0
28 条申报中的 25 条
About Gorman Kevin Charles
GORMAN KEVIN CHARLES is a Director at Neurocrine Biosciences INC and Xencor Inc. He has filed 28 disclosures in total, and across the recent sample of 28 filings, the aggregated amounts are EUR 941 of purchases and EUR 36,423,235 of sales, with filings ranging from 2016-01-13 to 2026-07-08.
